# Sedivention

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sedivention

- Industry: Medical Devices & Equipment
- Headquarters: Munich, Germany
- Website: www.sedivention.com
- Total disclosed funding: $3.4M
- Latest round: Seed (Apr 21, 2026)
- Investors on record: 5

## About

Founded in 2021 by André Burch and Dr.-Ing. Andreas Brocker and based in Bayern, Germany, Sedivention GmbH specializes in medical devices designed for obesity treatment. The current CEO is Dr.-Ing. Andreas Brocker. In April 2026, Sedivention GmbH? raised EUR 2.9 million in seed funding led by BMP, with participation from superangels, Terumo Medical Corporation and Cambridge Capital Management. High-Tech Gruenderfonds and other unspecified investors also participated in the round.

Sedivention GmbH specializes in the development of medical devices aimed at treating obesity through minimally invasive procedures. The firm’s core offering is cryo-ablation therapy designed to target the gastric trunks of the vagus nerve, which regulates appetite and reduces the feeling of hunger. This outpatient procedure, which takes approximately 20 minutes, employs cryogenic technology to safely and effectively alter the nerve functions related to hunger signals. Sedivention's products are primarily targeted at adult patients suffering from obesity, with a focus on markets in the United States and Europe.

The business transactions within Sedivention GmbH are structured primarily around healthcare providers and directly to consumers, focusing on the delivery of its cryo-ablation therapy. Revenue is generated through partnerships with medical facilities and direct sales to clinics specializing in obesity treatments.

The company will use the April 2026 funding to support its product development and expansion plans initiatives.

## Funding rounds

- Seed, Apr 21, 2026, $3.4M — BMP, Cambridge Capital Management, Terumo Medical Corporation, High-Tech Gruenderfonds, Superangels

## Investors

- BMP (https://capitalatlas.ai/funds/bmp) — Seed
- Cambridge Capital Management (https://capitalatlas.ai/funds/cambridge-capital-management) — Seed
- Terumo Medical Corporation — Seed
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- Superangels (https://capitalatlas.ai/funds/superangels) — Seed
